Logo image of CSTM

CONSTELLIUM SE (CSTM) Stock Fundamental Analysis

NYSE:CSTM - New York Stock Exchange, Inc. - FR0013467479 - Common Stock - Currency: USD

13.45  -0.06 (-0.44%)

Fundamental Rating

5

Overall CSTM gets a fundamental rating of 5 out of 10. We evaluated CSTM against 156 industry peers in the Metals & Mining industry. CSTM has a medium profitability rating, but doesn't score so well on its financial health evaluation. CSTM is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

CSTM had positive earnings in the past year.
In the past year CSTM had a positive cash flow from operations.
CSTM had positive earnings in 4 of the past 5 years.
CSTM had a positive operating cash flow in each of the past 5 years.
CSTM Yearly Net Income VS EBIT VS OCF VS FCFCSTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

CSTM has a Return On Assets of 3.41%. This is in the better half of the industry: CSTM outperforms 70.51% of its industry peers.
CSTM's Return On Equity of 23.63% is amongst the best of the industry. CSTM outperforms 93.59% of its industry peers.
The Return On Invested Capital of CSTM (12.50%) is better than 91.67% of its industry peers.
CSTM had an Average Return On Invested Capital over the past 3 years of 8.33%. This is below the industry average of 10.98%.
The 3 year average ROIC (8.33%) for CSTM is below the current ROIC(12.50%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.41%
ROE 23.63%
ROIC 12.5%
ROA(3y)3.45%
ROA(5y)3.08%
ROE(3y)23.43%
ROE(5y)N/A
ROIC(3y)8.33%
ROIC(5y)8.11%
CSTM Yearly ROA, ROE, ROICCSTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 -150

1.3 Margins

CSTM has a better Profit Margin (1.33%) than 63.46% of its industry peers.
CSTM's Profit Margin has declined in the last couple of years.
The Operating Margin of CSTM (4.03%) is comparable to the rest of the industry.
CSTM's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 11.88%, CSTM is in line with its industry, outperforming 44.23% of the companies in the same industry.
CSTM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.03%
PM (TTM) 1.33%
GM 11.88%
OM growth 3Y-14.91%
OM growth 5Y-4.66%
PM growth 3Y-43.25%
PM growth 5Y-5.23%
GM growth 3Y6.67%
GM growth 5Y5.15%
CSTM Yearly Profit, Operating, Gross MarginsCSTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CSTM is still creating some value.
Compared to 1 year ago, CSTM has less shares outstanding
Compared to 5 years ago, CSTM has more shares outstanding
CSTM has a worse debt/assets ratio than last year.
CSTM Yearly Shares OutstandingCSTM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CSTM Yearly Total Debt VS Total AssetsCSTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 3.32 indicates that CSTM is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.32, CSTM is doing good in the industry, outperforming 61.54% of the companies in the same industry.
A Debt/Equity ratio of 2.56 is on the high side and indicates that CSTM has dependencies on debt financing.
CSTM has a Debt to Equity ratio of 2.56. This is amonst the worse of the industry: CSTM underperforms 92.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.56
Debt/FCF N/A
Altman-Z 3.32
ROIC/WACC1.5
WACC8.33%
CSTM Yearly LT Debt VS Equity VS FCFCSTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

CSTM has a Current Ratio of 1.24. This is a normal value and indicates that CSTM is financially healthy and should not expect problems in meeting its short term obligations.
CSTM has a Current ratio of 1.24. This is in the lower half of the industry: CSTM underperforms 78.21% of its industry peers.
A Quick Ratio of 0.53 indicates that CSTM may have some problems paying its short term obligations.
With a Quick ratio value of 0.53, CSTM is not doing good in the industry: 89.10% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.24
Quick Ratio 0.53
CSTM Yearly Current Assets VS Current LiabilitesCSTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

6

3. Growth

3.1 Past

CSTM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -33.17%.
The Earnings Per Share has been growing slightly by 3.27% on average over the past years.
Looking at the last year, CSTM shows a very strong growth in Revenue. The Revenue has grown by 81.94%.
CSTM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.43% yearly.
EPS 1Y (TTM)-33.17%
EPS 3Y-38.65%
EPS 5Y3.27%
EPS Q2Q%124.55%
Revenue 1Y (TTM)81.94%
Revenue growth 3Y6.04%
Revenue growth 5Y4.43%
Sales Q2Q%8.63%

3.2 Future

Based on estimates for the next years, CSTM will show a very strong growth in Earnings Per Share. The EPS will grow by 69.72% on average per year.
CSTM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.03% yearly.
EPS Next Y178.67%
EPS Next 2Y98.45%
EPS Next 3Y69.72%
EPS Next 5YN/A
Revenue Next Year11.65%
Revenue Next 2Y11.82%
Revenue Next 3Y14.03%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CSTM Yearly Revenue VS EstimatesCSTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
CSTM Yearly EPS VS EstimatesCSTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 24.45, the valuation of CSTM can be described as rather expensive.
CSTM's Price/Earnings ratio is a bit cheaper when compared to the industry. CSTM is cheaper than 69.87% of the companies in the same industry.
CSTM is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.86, which is the current average of the S&P500 Index.
CSTM is valuated reasonably with a Price/Forward Earnings ratio of 8.31.
CSTM's Price/Forward Earnings ratio is rather cheap when compared to the industry. CSTM is cheaper than 82.05% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CSTM to the average of the S&P500 Index (21.43), we can say CSTM is valued rather cheaply.
Industry RankSector Rank
PE 24.45
Fwd PE 8.31
CSTM Price Earnings VS Forward Price EarningsCSTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CSTM is valued cheaply inside the industry as 92.31% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.51
CSTM Per share dataCSTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

CSTM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CSTM has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CSTM's earnings are expected to grow with 69.72% in the coming years.
PEG (NY)0.14
PEG (5Y)7.49
EPS Next 2Y98.45%
EPS Next 3Y69.72%

More info and screens

0

5. Dividend

5.1 Amount

CSTM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CONSTELLIUM SE

NYSE:CSTM (6/27/2025, 2:13:47 PM)

13.45

-0.06 (-0.44%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)07-21 2025-07-21/bmo
Inst Owners95.64%
Inst Owner Change-2.11%
Ins Owners1.83%
Ins Owner ChangeN/A
Market Cap1.92B
Analysts84
Price Target17.6 (30.86%)
Short Float %2.14%
Short Ratio1.6
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-337.89%
Min EPS beat(2)-952.86%
Max EPS beat(2)277.07%
EPS beat(4)2
Avg EPS beat(4)-181.55%
Min EPS beat(4)-952.86%
Max EPS beat(4)277.07%
EPS beat(8)2
Avg EPS beat(8)-114.34%
EPS beat(12)3
Avg EPS beat(12)-87.57%
EPS beat(16)6
Avg EPS beat(16)-7.76%
Revenue beat(2)1
Avg Revenue beat(2)0.75%
Min Revenue beat(2)-1.53%
Max Revenue beat(2)3.03%
Revenue beat(4)1
Avg Revenue beat(4)-3.76%
Min Revenue beat(4)-9.9%
Max Revenue beat(4)3.03%
Revenue beat(8)2
Avg Revenue beat(8)-2.62%
Revenue beat(12)5
Avg Revenue beat(12)-0.54%
Revenue beat(16)9
Avg Revenue beat(16)1.13%
PT rev (1m)0%
PT rev (3m)-8%
EPS NQ rev (1m)0%
EPS NQ rev (3m)12.25%
EPS NY rev (1m)-0.04%
EPS NY rev (3m)-14.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-12.16%
Revenue NY rev (1m)-4.14%
Revenue NY rev (3m)-5.92%
Valuation
Industry RankSector Rank
PE 24.45
Fwd PE 8.31
P/S 0.15
P/FCF N/A
P/OCF 6.46
P/B 2.58
P/tB 3.18
EV/EBITDA 4.51
EPS(TTM)0.55
EY4.09%
EPS(NY)1.62
Fwd EY12.03%
FCF(TTM)-0.75
FCFYN/A
OCF(TTM)2.08
OCFY15.48%
SpS92.34
BVpS5.21
TBVpS4.23
PEG (NY)0.14
PEG (5Y)7.49
Profitability
Industry RankSector Rank
ROA 3.41%
ROE 23.63%
ROCE 15.83%
ROIC 12.5%
ROICexc 12.96%
ROICexgc 13.54%
OM 4.03%
PM (TTM) 1.33%
GM 11.88%
FCFM N/A
ROA(3y)3.45%
ROA(5y)3.08%
ROE(3y)23.43%
ROE(5y)N/A
ROIC(3y)8.33%
ROIC(5y)8.11%
ROICexc(3y)8.79%
ROICexc(5y)8.68%
ROICexgc(3y)9.69%
ROICexgc(5y)9.98%
ROCE(3y)10.54%
ROCE(5y)10.26%
ROICexcg growth 3Y-18.02%
ROICexcg growth 5Y-6.42%
ROICexc growth 3Y-13.61%
ROICexc growth 5Y-3.24%
OM growth 3Y-14.91%
OM growth 5Y-4.66%
PM growth 3Y-43.25%
PM growth 5Y-5.23%
GM growth 3Y6.67%
GM growth 5Y5.15%
F-Score8
Asset Turnover2.55
Health
Industry RankSector Rank
Debt/Equity 2.56
Debt/FCF N/A
Debt/EBITDA 2.29
Cap/Depr 134.34%
Cap/Sales 3.07%
Interest Coverage 6.05
Cash Conversion 35.72%
Profit Quality N/A
Current Ratio 1.24
Quick Ratio 0.53
Altman-Z 3.32
F-Score8
WACC8.33%
ROIC/WACC1.5
Cap/Depr(3y)117.66%
Cap/Depr(5y)102.03%
Cap/Sales(3y)4.56%
Cap/Sales(5y)4.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.17%
EPS 3Y-38.65%
EPS 5Y3.27%
EPS Q2Q%124.55%
EPS Next Y178.67%
EPS Next 2Y98.45%
EPS Next 3Y69.72%
EPS Next 5YN/A
Revenue 1Y (TTM)81.94%
Revenue growth 3Y6.04%
Revenue growth 5Y4.43%
Sales Q2Q%8.63%
Revenue Next Year11.65%
Revenue Next 2Y11.82%
Revenue Next 3Y14.03%
Revenue Next 5YN/A
EBIT growth 1Y39.57%
EBIT growth 3Y-9.78%
EBIT growth 5Y-0.44%
EBIT Next Year102.52%
EBIT Next 3Y37.28%
EBIT Next 5YN/A
FCF growth 1Y-191.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-30.16%
OCF growth 3Y-5.53%
OCF growth 5Y-7.6%